Assenagon Asset Management’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-20,946
| Closed | -$712K | – | 1327 |
|
|
2024
Q3 | $712K | Sell |
20,946
-118,216
| -85% | -$4.02M | ﹤0.01% | 1165 |
|
|
2024
Q2 | $5.15M | Buy |
139,162
+48,231
| +53% | +$1.79M | 0.01% | 606 |
|
|
2024
Q1 | $3.82M | Buy |
+90,931
| New | +$3.82M | 0.01% | 649 |
|